Hartwell Center for Bioinformatics & Biotechnology

  • Hartwell Center for Bioinformatics and Biotechnology
  • Hartwell Center for Bioinformatics and Biotechnology
  • Hartwell Center for Bioinformatics and Biotechnology
  • Hartwell Center for Bioinformatics and Biotechnology
  • Hartwell Center for Bioinformatics and Biotechnology


The Hartwell Center for Bioinformatics & Biotechnology is a unique integration of high-throughput biotechnology resources, bioinformatics resources and academic programs; designed to provide St. Jude with state-of-the-art tools for discovery. These tools include high-throughput DNA sequence analysis, gene expression analysis, macromolecular synthesis, molecular interaction analysis and other methodologies. Many of these are high-throughput biotechnologies that allow large-scale biology questions to be addressed and are fundamentally changing the way science is conducted. They typically generate enormous datasets and demand a strong bioinformatics staff, software/database development support, and a high-performance computing environment. The Hartwell Center, through its expert staff and significant resources, is pleased to offer these capabilities in support of St. Jude research programs.

The Hartwell Center is unique in integrating high-throughput biotechnology services with research computing and bioinformatics support to provide St. Jude research programs the best possible research environment. The Center has evolved since the mid-1980s to include the range and scope of activities it offers today. The investment made in these "tools for discovery" have led to contributions to most research efforts and publications produced by St. Jude faculty and numerous discoveries impacting the diagnosis, classification, and treatment of pediatric diseases.

The Center currently employs 19 staff members including 5 PhD-level staff scientists, and is supported by ALSAC, Cancer Center Support Grant funds, program project funds, our charge-back system, and a major private donor.

Our mission is to be the best in applying modern bioinformatics and biotechnology to the study and treatment of pediatric catastrophic diseases.